BioNTech SE (BNTX) Net Equity Issued and Repurchased (2018 - 2022)

BioNTech SE has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $124.0 million in Q1 2022.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $124.0 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $124.0 million (down 37.82% YoY) and the FY2022 annual result came in at $112.7 million, down 40.79% from the prior year.
• Net Equity Issued and Repurchased grew to $124.0 million in Q1 2022 per BNTX's latest filing, from -$184.1 million in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $193.8 million in Q2 2021 and troughed at -$321.1 million in Q4 2018.
• A 5-year average of -$38.9 million and a median of $86.92 in 2020 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2020 and 2021: Net Equity Issued and Repurchased soared 100.0% in 2020, then plunged 211768748.9% in 2021.
• Over 5 years, Net Equity Issued and Repurchased stood at -$321.1 million in 2018, then advanced by 14.57% to -$274.4 million in 2019, then jumped by 100.0% to $86.92 in 2020, then slumped by 211768748.9% to -$184.1 million in 2021, then jumped by 167.38% to $124.0 million in 2022.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $124.0 million, -$184.1 million, and $189.7 million for Q1 2022, Q4 2021, and Q3 2021 respectively.